Company Overview and News

 
ON vs. SLAB: Which Stock Is the Better Value Option?

2018-09-13 zacks
Investors interested in Semiconductor - Analog and Mixed stocks are likely familiar with ON Semiconductor Corp. (ON - Free Report) and Silicon Laboratories (SLAB - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
SLAB ON

 
ON vs. SLAB: Which Stock Is the Better Value Option?

2018-08-27 zacks
Investors looking for stocks in the Semiconductor - Analog and Mixed sector might want to consider either ON Semiconductor Corp. (ON - Free Report) or Silicon Laboratories (SLAB - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
SLAB ON

41
ON or SLAB: Which Is the Better Value Stock Right Now?

2018-08-11 zacks
Investors with an interest in Semiconductor - Analog and Mixed stocks have likely encountered both ON Semiconductor Corp. (ON - Free Report) and Silicon Laboratories (SLAB - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
SLAB REI ON ADMP

 
Mass Confusion Leads to Cancellation of SIGM Stock Trades

2018-08-01 investorplace
Semiconductor business Sigma Designs (NASDAQ:SIGM) has had a tough year — unsurprising for a company is in the midst of a voluntary liquidation plan. SIGM stock briefly made its way toward $7 per share at the beginning of this year, but the share price has since been languishing around $6.10. Investors are waiting for Sigma to confirm its next moves.
SIGM SLAB

 
Silicon Laboratories, Inc. (SLAB) CEO George Tuttle on Q2 2018 Results - Earnings Call Transcript

2018-07-25 seekingalpha
Good morning. My name is James, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Silicon Labs Second Quarter Fiscal 2018 Earnings Conference Call. At this time, all lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. [Operator Instructions]
SIGM SLAB IFK IFX

 
 
Silicon Laboratories (SLAB) Beats Q2 Earnings and Revenue Estimates

2018-07-25 zacks
Silicon Laboratories (SLAB - Free Report) just came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items.
SLAB MS

42
What will chip makers say about the trade war? - MarketWatch

2018-07-18 marketwatch
Semiconductor earnings seen growing 38%, but effects of China tariffs in forecasts are where the big uncertainty lies
MRVL XLNX LRCX SLAB HXSCF BC94 CRUS SMSN AMD NVDA MPWR SWKS TER MU AMAT AVGO ADI MKSI BRCM INTC QCOM SMSD HXSCL

11
Growth Meets Value At NVE Corporation

2018-07-05 seekingalpha
Smaller sensors and couplers with higher sensitivity and power efficiency will replace the traditional ones in the long run as circuit boards get smaller.
ABT SLAB NVEC TXN AVGO ADI BRCM MXIM ABT

11
7 Megatrend Stocks With Long-Term Upside Potential

2018-07-03 investorplace - 2
As investors, we often jump on the flavor-of-the-week in the hopes of profiting from the immediate momentum. However, some of the best returns are found in companies levered towards next-generation technologies and innovations. These so-called megatrend stocks are extremely viable for your portfolio; they just require some patience.
IBM SLAB GOOGL RTN MSFT ISRG BTAI NVDA GOOG TSM YEXT

27
Zacks.com featured highlights include: Illumina, Lululemon, Surmodics and ConocoPhillips

2018-06-22 zacks
Chicago, IL – June 22, 2018 - Stocks in this week’s article Illumina, Inc. (ILMN - Free Report) , Lululemon Athletica Inc. (LULU - Free Report) , Surmodics, Inc. (SRDX - Free Report) and ConocoPhillips (COP - Free Report) .
SLAB TXN MPX ILMN COP LULU SRDX MS FIVE

23
Zacks.com featured highlights include: Marine Products, Five Below, Schnitzer Steel, Vectrus and Expeditors International

2018-06-22 zacks
Chicago, IL – June 22, 2018 - Stocks in this week’s article Marine Products Corp. (MPX - Free Report) , Five Below Inc. (FIVE - Free Report) , Schnitzer Steel Industries Inc. (SCHN - Free Report) , Vectrus Inc. (VEC - Free Report) and Expeditors International of Washington Inc. (EXPD - Free Report) .
VEC SLAB TXN SCHN MPX EXPD MS FIVE

196
The Zacks Analyst Blog Highlights: Micron, NVIDIA, Texas Instruments, Diodes and Silicon Laboratories

2018-06-22 zacks
Chicago, IL –June 22, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Micron Technology, Inc. (MU - Free Report) , NVIDIA Corp. (NVDA - Free Report) , Texas Instruments Inc. (TXN - Free Report) , Diodes Inc.
SLAB DIOD TXN NVDA ENPH MU PATK HEAR BZ MS AMWD

189
Micron's Blowout Earnings Drive Chipmakers: 5 Top Picks

2018-06-21 zacks - 1
Micron Technology, Inc. (MU - Free Report) reported stellar sales and profits in the fiscal third-quarter 2018, fueled by high demand for chips that store data in mobile devices and components. The chipmaker’s upbeat performance once again crushed all doubts surrounding the stock and restored faith in the semiconductor market amid trade war concerns.
SLAB DIOD TXN NVDA MU BZ MS

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to SLAB / Silicon Laboratories, Inc. on message board site Silicon Investor.

Silicon Laboratories - SLAB Silicon Laboratories - SLAB Silicon Laboratories - SLAB SLAB Ready to Tank? SLAB Ready to Tank? SLAB Ready to Tank?
Dr Reedyu0027sLaboratories (RDY) Dr Reedyu0027sLaboratories (RDY) Dr Reedyu0027sLaboratories (RDY) Silicon Laboratories - SLAB Silicon Laboratories - SLAB Silicon Laboratories - SLAB
ULAB.....USLAB.COM...CMGI? ULAB.....USLAB.COM...CMGI? ULAB.....USLAB.COM...CMGI?
CUSIP: 826919102